← Open Payments lookup

BRIAN LEE: Open Payments

NPI 1881768596 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$250 in 11 payments from 9 companies in 2025. Trend: 2023 $276 · 2024 $331 · 2025 $250

Food & beverage: $250
CompanyPaymentsAmount
Novo Nordisk Inc2$49
Amgen Inc.2$45
Forte Bio-Pharma LLC1$31
Abbott Laboratories1$28
Averitas Pharma Inc.1$26
Dexcom, Inc.1$21
Bayer Healthcare Pharmaceuticals Inc.1$19
AstraZeneca Pharmaceuticals LP1$16
Orexo US, Inc.1$15

Products named: OTEZLA, PROLATE, FREESTYLE LIBRE 3, QUTENZA, Dexcom G6 Transmitter, Kerendia, AIRSUPRA, Zubsolv.

Industry payments across NV — which companies pay providers there.